AstraZeneca Resumes COVID-19 Trials After Halt Over Adverse Reaction

AstraZeneca (AZN) announced on Saturday that its Phase 3 COVID-19 study would resume, days after a participant fell ill.

The company said in a statement that "the standard review process had triggered a voluntary pause," to all global trials on September 6, and that the Medicines Health Regulatory Authority had given the green light to resume the trials conducted through the University of Oxford after reviewing the safety data.

The company says that it will "continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably, and at no profit during this pandemic."

While the company has been approved to continue testing in the UK, it is unclear whether they can resume trials elsewhere. At least 18,000 people have received the experimental treatment as part of the trial.

Earlier this week, AstraZeneca CEO Pascal Soriot said during a private conference call  that the "potentially unexplained illness" occurred in a UK woman who displayed neurological symptoms consistent with transverse myelitis - a spinal inflammatory disorder, according to STAT News. Soriot also confirmed that the company's clinical research trials had been halted in July after a different participant experienced neurological symptoms which were found to be unrelated to the experimental vaccine.

"In large trials such as this, it is expected that some participants will become unwell, and every case must be carefully evaluated to ensure careful assessment of safety," reads a statement from Oxford. 

1 2
View single page >> |

Disclosure: Copyright ©2009-2019 Media, LTD; All Rights Reserved. Zero Hedge is intended for Mature Audiences. Familiarize yourself with our legal and use policies every ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.